Condition : Knee Osteoarthritis Intervention : Device: Compex Rehab Sponsors : Orthopaedic Research Foundation; DJO Incorporated Recruiting - verified November 2013

Primary Objective: To assess, in the same study, the safety of sarilumab and tocilizumab in patients with rheumatoid arthritis (RA) who are inadequate responders to or intolerant of tumor necrosis fac...

Condition : Rheumatoid Arthritis Interventions : Drug: Sarilumab SAR153191 (REGN88); Drug: Etanercept; Drug: Adalimumab Sponsors : Sanofi; Sanofi; Regeneron Pharmaceuticals Recruiting - verified Septe...

Condition : Rheumatoid Arthritis Interventions : Drug: Sarilumab SAR153191 (REGN88); Drug: Etanercept; Drug: Adalimumab Sponsors : Sanofi; Regeneron Pharmaceuticals Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Drug: Sarilumab SAR153191 (REGN88); Drug: Etanercept; Drug: Adalimumab Sponsors : Sanofi; Regeneron Pharmaceuticals Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Sponsors : UCB, Inc.; UCB Pharma SA Recruiting - verified February 2014

Condition : Psoriatic Arthritis Interventions : Drug: golimumab; Drug: methotrexate Sponsor : Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Sponsors : UCB, Inc.; UCB Pharma SA Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Sponsors : UCB, Inc.; UCB Pharma SA Recruiting - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Drug: Rituximab Sponsor : Biocad Recruiting - verified February 2014